A Study of Adalimumab for the Maintenance of Clinical Remission in Japanese Subjects With Crohn's Disease

Autores
Categoría Estudio primario
Registro de estudiosclinicaltrials.gov
Año 2007
Cargando información sobre las referencias
To demonstrate the efficacy and safety of adalimumab for the maintenance of clinical remission in Japanese subjects with Crohn\'s disease.
Epistemonikos ID: ef8ca6b492057d7472b5a973182608764475863b
First added on: Jul 30, 2018